Skip to content

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Clinical and Radiological Outcomes of Medacta Shoulder System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05926622
Enrollment
200
Registered
2023-07-03
Start date
2022-03-15
Completion date
2037-03-31
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Fracture, Primary Osteoarthritis, Revision of Shoulder Arthroplasty, Rheumatoid Arthritis Shoulder, Rotator Cuff Tear Arthropathy, Secondary Osteoarthritis

Brief summary

This is a post-marketing surveillance on Medacta Shoulder System

Interventions

None listed

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years * Patient with one of the following diagnosis: Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty

Exclusion criteria

* Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)

Design outcomes

Primary

MeasureTime frameDescription
Survival Rate10 yearsKaplan Meier method

Secondary

MeasureTime frameDescription
Radiographic performance of the implants evaluating presence of radiolucencies3 months, 1, 2, 5 and 10 yearspresence of radiolucencies
Clinical outcome evaluating Constant & Murley Score1, 2, 5 and 10 yearsConstant & Murley Score (CMS): The CMS is a multi-item functional scale assessing pain, ADL, ROM and strength of the affected shoulder. Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively
Functional outcome evaluating Oxford Shoulder Score1, 2, 5 and 10 yearsOxford Shoulder Score (OSS): The Oxford Shoulder Score is a unidimensional score comprising 12 questions. Starting with 1 (best/fewest symptoms) to 5 (worst/most severe) which is awarded to correspond to the patient's symptoms. The total gives a minimum score of 12 and a maximum of 60. A higher score implies a greater degree of disability.
Patient evaluation quality of life1, 2, 5 and 10 yearsEQ-5D-5L: The EQ-5D-5L is a self-assessed, health related, quality of life questionnaire. The scale measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Typically it is calculated by assigning a numerical value to each response level (i.e., 1 for no problems, 5 for extreme problems/unable to) and summing these values across the five items, resulting in a score from 5 (no problems on any dimension) to 25 (extreme problems on all dimensions)
Adverse eventsup to 10 yearsrecord of adverse event

Countries

France

Contacts

Primary ContactArianna Girardi
girardi@medacta.ch+41 91 696 60 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026